| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | FATE THERAPEUTICS INC | 1,300,000 | 8,411,000 | 0.45% | ||
| 52 | IRADIMED CORP | 355,684 | 8,277,000 | 0.44% | ||
| 53 | BIOLINERX LTD | 3,100,000 | 8,246,000 | 0.44% | ||
| 54 | VERACYTE INC | 736,196 | 8,201,000 | 0.44% | ||
| 55 | VERASTEM INC | 1,050,000 | 7,917,000 | 0.43% | ||
| 56 | FLEXION THERAPEUTICS INC | 348,204 | 7,622,000 | 0.41% | ||
| 57 | TENAX THERAPEUTICS INC | 1,968,631 | 7,264,000 | 0.39% | ||
| 58 | MEDGENICS INC | 1,113,900 | 6,828,000 | 0.37% | ||
| 59 | TONIX PHARMACEUTICALS HOLDING | 760,748 | 6,824,000 | 0.37% | ||
| 60 | SCYNEXIS INC | 775,000 | 6,812,000 | 0.37% | ||
| 61 | REDHILL BIOPHARMA LTD | 384,281 | 6,767,000 | 0.36% | ||
| 62 | ACCURAY INCORPORATED COM | 1,000,000 | 6,740,000 | 0.36% | ||
| 63 | ABIOMED INC | 100,000 | 6,573,000 | 0.35% | ||
| 64 | ONCOTHYREON INC COM N/C EFF 6/ | 1,700,000 | 6,358,000 | 0.34% | ||
| 65 | NOVADAQ TECHNOLOGIES INC | 523,863 | 6,344,000 | 0.34% | ||
| 66 | Egalet Corp | 434,750 | 6,273,000 | 0.34% | ||
| 67 | Dipexium Pharmaceuticals Inc | 475,000 | 6,042,000 | 0.32% | ||
| 68 | BIODELIVERY SCIENCES INTL IN | 750,000 | 5,970,000 | 0.32% | Call | |
| 69 | CONTRAFECT CORP COM | 1,418,440 | 5,957,000 | 0.32% | ||
| 70 | XOMA CORP DEL | 1,500,000 | 5,820,000 | 0.31% | ||
| 71 | BIODEL INC | 5,580,034 | 5,747,000 | 0.31% | ||
| 72 | BIOTA PHARMACEUTIALS INC COM | 2,611,711 | 5,406,000 | 0.29% | ||
| 73 | DISCOVERY LABORATORIES INC N | 7,822,500 | 5,319,000 | 0.29% | ||
| 74 | COLLEGIUM PHARMACEUTICAL INC COM | 297,200 | 5,302,000 | 0.28% | ||
| 75 | DURECT CORP | 2,195,378 | 5,247,000 | 0.28% | ||
| 76 | Progenics Pharmaceuticals Inc | 600,000 | 4,476,000 | 0.24% | Call | |
| 77 | OHR PHARMACEUTICAL INC | 1,775,000 | 4,455,000 | 0.24% | ||
| 78 | CARDICA INC | 8,874,992 | 4,429,000 | 0.24% | ||
| 79 | EPIRUS BIOPHARMA | 775,000 | 4,425,000 | 0.24% | ||
| 80 | ORASURE TECHNOLOGIES INC | 685,528 | 3,695,000 | 0.20% | ||
| 81 | AQUINOX PHARMACEUTICALS INC | 531,768 | 3,690,000 | 0.20% | ||
| 82 | ZOSANO PHARMA CORP | 485,000 | 3,516,000 | 0.19% | ||
| 83 | RITTER PHARMACEUTICALS INC | 778,000 | 3,462,000 | 0.19% | ||
| 84 | CAS MED SYS INC | 2,618,296 | 3,351,000 | 0.18% | ||
| 85 | RXI PHARMACEUTICALS CORP NEW | 6,126,482 | 3,002,000 | 0.16% | ||
| 86 | BOVIE MEDICAL CORP COM | 947,400 | 2,643,000 | 0.14% | ||
| 87 | WRIGHT MEDICAL GROUP N.V. | 100,000 | 2,499,000 | 0.13% | ||
| 88 | UNILIFE CORP | 1,150,000 | 2,473,000 | 0.13% | ||
| 89 | CIDARA THERAPEUTICS INC | 150,000 | 2,103,000 | 0.11% | ||
| 90 | TearLab Corp. | 914,499 | 1,847,000 | 0.10% | ||
| 91 | MEDIWOUND ORD | 119,868 | 847,000 | 0.05% | ||
| 92 | CAPRICOR THERAPEUTICS INC | 118,002 | 596,000 | 0.03% | ||
| 93 | STRATA SKIN SCIENCES INC COM | 383,625 | 441,000 | 0.02% | ||
| 94 | TRIVASCULAR TECHNOLOGIES INC | 6,032 | 32,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-006089, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
